Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × Imatinib Mesylate × Clear all

NCT00451997 2012-08-01

Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes